Advanced Enzyme Technologies Approves Open Market Buyback of Equity Shares, Sets Maximum Price at ₹500 per Share
Advanced Enzyme Technologies Limited (AETL) has approved a buyback of its equity shares through an open market route via stock exchanges. The company’s Board, in a meeting held on August 8, 2026, granted approval for the offer, setting out specific financial limits and operational requirements for the transaction.The resolution permits the purchase of fully paid-up equity shares at a maximum price not exceeding ₹500 per Equity Share (the Maximum Buyback Price). The overall aggregate amount set for the buyback does not exceed ₹697,000,000 (Rupees Six Hundred Ninety Seven Million only).
The offer has limits established across various thresholds. Key financial details regarding the buyback are summarized below:
| Metric | Limit / Value | Basis |
|---|---|---|
| Maximum Buyback Size | ₹697,000,000 | Not exceeding 9.99% of paid-up equity share capital and free reserves (standalone) or 5.09% (consolidated). |
| Minimum Buyback Size | ₹522,750,000 | Must utilize at least 75% of the Maximum Buyback Size. |
| Indicative Maximum Shares | 1,394,000 | Based on the maximum buyback size. The indicative number represents 1.24% of the total paid-up Equity Shares as of August 8, 2026. |
The company also specified internal operational requirements for the offer, including ensuring that at least 40% of the Buyback Size is utilized within the initial half of the Offer Period. Furthermore, AETL confirmed that it shall not exceed 25% of the total number of Equity Shares in a single financial year during this process.
Pricing and Valuation Details
The Maximum Buyback Price of ₹500 was determined after considering various factors, including market trends and the company’s net worth. The price represents multiple premiums over the volume weighted average market price (VWAP) observed on BSE and NSE following the date of intimation to the stock exchanges (August 1, 2026).
The closing market price of the Equity Shares, as recorded on the trading day prior to the Board Meeting (August 8, 2026), stood at ₹324.40 on BSE and ₹324.35 on NSE. This reference data was utilized in calculating the premiums associated with the Maximum Buyback Price.
Operational Commitments and Governance Structure
The company confirmed that all shares are frequently traded and committed to implementing the buyback through open market purchases via stock exchanges. The offer is structured as a cash payment only.
A dedicated Buyback Committee was constituted to oversee the process, comprising Mr. Mukund Kabra (Whole Time Director), Mr. Vinodkumar Jajoo (Independent Director), and Mr. Sanjay Basantani (Company Secretary & Head Legal).
Management confirmed that nothing in the resolution confers any right on any shareholder to offer shares or obligation on the Company or Board to buy back any shares, and stated that the Buyback is not intended to cause a change in control or management of the company.
ADVENZYMES Stock Price Movement
Advanced Enzyme Technologies Limited shares today slipped by 0.13% to close at ₹300.85. The stock recorded a traded volume of 159,628 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.